Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Journal of Biological Chemistry
|
January 5, 2002
Activation of human MutS homologs by 8-oxo-guanine DNA damage
Anthony Mazurek, Mark Berardini, Richard Fishel
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2009
Sequence context effect for hMSH2-hMSH6 mismatch-dependent activation
Anthony Mazurek, Christopher N Johnson, Markus W Germann, et al.
Cancer Cell
|
July 19, 2002
HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions
Christopher D Heinen, Teresa Wilson, Anthony Mazurek, et al.
Cancer Discovery
|
July 4, 2012
DDX5 regulates DNA replication and is required for cell proliferation in a subset of breast cancer cells
Anthony Mazurek, Weijun Luo, Alexander Krasnitz, et al.
The Journal of Biological Chemistry
|
December 22, 2004
DNA mismatch repair-dependent response to fluoropyrimidine-generated damage
Mark Meyers, Mark W Wagner, Anthony Mazurek, et al.
Cell Reports
|
June 10, 2014
Acquired dependence of acute myeloid leukemia on the DEAD-box RNA helicase DDX5
Anthony Mazurek, Youngkyu Park, Cornelius Miething, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2011
Reversible suppression of an essential gene in adult mice using transgenic RNA interference
Katherine McJunkin, Anthony Mazurek, Prem K Premsrirut, et al.
Cell Cycle (Georgetown, Tex.)
|
December 28, 2020
Sustained mTORC1 activity during palbociclib-induced growth arrest triggers senescence in ER+ breast cancer cells
Reeja S Maskey, Fang Wang, Elyssa Lehman, et al.
Metabolites
|
January 6, 2019
Palbociclib and Fulvestrant Act in Synergy to Modulate Central Carbon Metabolism in Breast Cancer Cells
Benedikt Warth, Amelia Palermo, Nicholas J W Rattray, et al.
Cell Chemical Biology
|
August 9, 2023
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer
Shikhar Sharma, Chi-Yeh Chung, Sean Uryu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Journal of Biological Chemistry
|
January 5, 2002
Activation of human MutS homologs by 8-oxo-guanine DNA damage
Anthony Mazurek, Mark Berardini, Richard Fishel
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2009
Sequence context effect for hMSH2-hMSH6 mismatch-dependent activation
Anthony Mazurek, Christopher N Johnson, Markus W Germann, et al.
Cancer Cell
|
July 19, 2002
HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions
Christopher D Heinen, Teresa Wilson, Anthony Mazurek, et al.
Cancer Discovery
|
July 4, 2012
DDX5 regulates DNA replication and is required for cell proliferation in a subset of breast cancer cells
Anthony Mazurek, Weijun Luo, Alexander Krasnitz, et al.
The Journal of Biological Chemistry
|
December 22, 2004
DNA mismatch repair-dependent response to fluoropyrimidine-generated damage
Mark Meyers, Mark W Wagner, Anthony Mazurek, et al.
Cell Reports
|
June 10, 2014
Acquired dependence of acute myeloid leukemia on the DEAD-box RNA helicase DDX5
Anthony Mazurek, Youngkyu Park, Cornelius Miething, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2011
Reversible suppression of an essential gene in adult mice using transgenic RNA interference
Katherine McJunkin, Anthony Mazurek, Prem K Premsrirut, et al.
Cell Cycle (Georgetown, Tex.)
|
December 28, 2020
Sustained mTORC1 activity during palbociclib-induced growth arrest triggers senescence in ER+ breast cancer cells
Reeja S Maskey, Fang Wang, Elyssa Lehman, et al.
Metabolites
|
January 6, 2019
Palbociclib and Fulvestrant Act in Synergy to Modulate Central Carbon Metabolism in Breast Cancer Cells
Benedikt Warth, Amelia Palermo, Nicholas J W Rattray, et al.
Cell Chemical Biology
|
August 9, 2023
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer
Shikhar Sharma, Chi-Yeh Chung, Sean Uryu, et al.
Page
of 1